Stilley William B. III
- SEC CIK
- 0001718069
No open-market purchases or sales filed in the past year.
Current role at each company
- ADIL Adial Pharmaceuticals, Inc.Directoras of May 25, 2023
- CHGA Change Agents Corporation.Directoras of Mar 8, 2023
- SYSX Sysorex, Inc.Directoras of Sep 10, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stilley William B. III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADIL Adial Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 (view filing) | Nov 29-30 | 2 days | Stilley William B. IIIChief Executive Officer | PPurchase | +20.6K | $2.67 | +$55.0K | +2.2%937.6K after | 2 lots |